rhnrg1 her3i (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
95
Structured Review
R&D Systems
rhnrg1 her3i
Rhnrg1 Her3i, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 125 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhnrg1/Recombinant+Human+NRG1-beta+1%2FHRG1-beta+1+EGF+Domain+Protein/pm38150867-60-5-9
Average 95 stars, based on 125 article reviews
Rhnrg1 Her3i, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 125 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhnrg1/Recombinant+Human+NRG1-beta+1%2FHRG1-beta+1+EGF+Domain+Protein/pm38150867-60-5-9
Average 95 stars, based on 125 article reviews
rhnrg1 her3i - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
other:Article Title: Neuregulin autocrine signaling promotes self-renewal of breast tumor-initiating cells by triggering HER2/HER3 activation Article Snippet: Dual inhibitors of HER2 and EGFR used are: lapatinib (LC Laboratories, L-4804) and afatinib (Selleck, S1011). Article Title: The novel antibody fusion protein rhNRG1-HER3i promotes heart regeneration by enhancing NRG1-ERBB4 signaling pathway. Article Snippet: Stimulating cardiomyocyte proliferation in the adult heart has emerged as a promising strategy for cardiac regeneration following myocardial infarction (MI).. The NRG1-ERBB4 signaling pathway has been implicated in the regulation of cardiomyocyte proliferation.. However, the therapeutic potential of recombinant human NRG1 (rhNRG1) has been limited due to the low expression of ERBB4 in adult cardiomyocytes. Article Title: NRG1-Fc improves metabolic health via dual hepatic and central action. Article Snippet: T47D cells were maintained in DMEM containing 10% FBS and starved for 12–16 hours in serum-free DMEM before treatments with Fc, NRG1-Fc, or Article Title: Neuregulin Autocrine Signaling Promotes Self-Renewal of Breast Tumor-Initiating Cells by Triggering HER2/HER3 Activation Article Snippet: Dual inhibitors of HER2 and EGFR used are: lapatinib (LC Laboratories, L-4804) and afatinib (Selleck Chemicals, S1011). Article Title: Characterization of the bioactive motif of neuregulin-1, a fibroblast-derived paracrine factor that regulates the constitutive color and the function of melanocytes in human skin Article Snippet: The commercially available Article Title: In vitro and in vivo development of the human intestinal niche at single cell resolution Article Snippet: This culture media was the base media for the eight culture conditions with varied concentrations of |